Brian Goff
Director, IDENIX PHARMACEUTICALS INC.
Companies
- Intellia TherapeuticsBoard member Jun 17, 2024 to now1
- Agios PharmaceuticalsBoard member Aug 9, 2022 to now2
- Agios PharmaceuticalsChief executive officer Aug 9, 2022 to now2
- Alexion PharmaceuticalsEVP & Chief Commercial Officer Jun 9, 2017 to Jul 23, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Agios Pharmaceuticals AGIO184,508 shares4$6.3M at $34.36Apr 2, 2026
Intellia Therapeutics NTLA32,609 shares5$374.4K at $11.48Jun 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 9, 2026Granted 9,200 shares of Intellia Therapeutics5
- Apr 2, 2026Sold 6,596 shares at $34.71 of Agios Pharmaceuticals4
- Apr 2, 2026Exercised options 13,500 shares of Agios Pharmaceuticals4
- Apr 2, 2026Sold 12,472 shares at $34.71 of Agios Pharmaceuticals4
- Apr 2, 2026Exercised options 25,528 shares of Agios Pharmaceuticals4
- Mar 2, 2026Sold 5,918 shares at $28.96 of Agios Pharmaceuticals6
- Mar 2, 2026Exercised options 13,000 shares of Agios Pharmaceuticals6
- Mar 2, 2026Sold 8,267 shares at $28.96 of Agios Pharmaceuticals6
- Mar 2, 2026Exercised options 18,000 shares of Agios Pharmaceuticals6
- Mar 2, 2026Sold 3,870 shares at $28.96 of Agios Pharmaceuticals6
- Mar 2, 2026Exercised options 8,500 shares of Agios Pharmaceuticals6
- Dec 30, 2025Sold 6,230 shares at $27.09 of Agios Pharmaceuticals7
- Dec 30, 2025Exercised options 12,750 shares of Agios Pharmaceuticals7
- Dec 30, 2025Sold 12,473 shares at $27.09 of Agios Pharmaceuticals7
- Dec 30, 2025Exercised options 25,528 shares of Agios Pharmaceuticals7
- Aug 8, 2025Sold 11,085 shares at $36.67 of Agios Pharmaceuticals8
- Aug 8, 2025Exercised options 22,691 shares of Agios Pharmaceuticals8
- Jun 24, 2025Sold 6,229 shares at $33.54 of Agios Pharmaceuticals9
- Jun 24, 2025Exercised options 12,750 shares of Agios Pharmaceuticals9
- Jun 24, 2025Sold 12,471 shares at $33.54 of Agios Pharmaceuticals9
- Jun 24, 2025Exercised options 25,527 shares of Agios Pharmaceuticals9
- Jun 11, 2025Granted 8,000 shares of Intellia Therapeutics10
- Mar 3, 2025Sold 8,794 shares at $35.54 of Agios Pharmaceuticals11
- Mar 3, 2025Sold 4,153 shares at $35.54 of Agios Pharmaceuticals11
- Mar 1, 2025Exercised options 18,000 shares of Agios Pharmaceuticals11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIntellia Therapeutics, Board member
- 2SEC EDGARAgios Pharmaceuticals, Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Mar 3, 2026
- 7SEC EDGARForm 4 filed Jan 2, 2026
- 8SEC EDGARForm 4 filed Aug 12, 2025
- 9SEC EDGARForm 4 filed Jun 26, 2025
- 10SEC EDGARForm 4 filed Jun 13, 2025
- 11SEC EDGARForm 4 filed Mar 4, 2025